Intranasal administration of insulin lowers amyloid-ß levels in rat model of diabetes

Indian Journal of Experimental Biology

Volumn 50, Issue 1, 2012, Pages 41-44

  Subramanian, Sarada ^a   John, Mathew ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

Alzheimer's disease; Amyloid ; Diabetes; Insulin; Streptozotocin

Indexed keywords

AMYLOID BETA PROTEIN; ANTIDIABETIC AGENT; INSULIN;

ALZHEIMER DISEASE; ANIMAL; ARTICLE; BRAIN; DISEASE MODEL; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL DIABETES MELLITUS; FEMALE; HYPERGLYCEMIA; INTRANASAL DRUG ADMINISTRATION; MEMORY; METABOLISM; PATHOLOGY; RAT; SPRAGUE DAWLEY RAT;

ADMINISTRATION, INTRANASAL; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BRAIN; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MEMORY; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 84855282751     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Morrison J H & Hof P R, Life and death of neurons in the aging brain, Science, 278 (1997) 412.
2. Hardy J & Selkoe D J, The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics, Science, 297 (2002) 353.
3. Craft S, The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged, Arch Neurol, 66 (2009) 300.
4. Roriz-Filho J S, Sa-Roriz T M, Rosset I, Camozzato A L, Santos A C, Chaves M L F, Moriguti J C & Roriz-Cruz M, (Pre)diabetes, brain aging and cognition, Biochim Biophys Acta, 1792 (2009) 432.
5. Jolivalt C J, Lee C, Beiswenger K K, Smith J L, Orlov M, Torrance M A & Masliah E, Defective insulin signaling pathway and increased glycogen synthase kinase-3 activity in the brain of diabetic mice: parallels with Alzheimer's disease and correction by insulin, J Neurosci Res, 86 (2008) 3265.
6. Lee Z G, Zhang W & Sima A A, Alzheimer-like changes in rat models of spontaneous diabetes, Diabetes, 56 (2007) 1817.
7. Jolivalt C G, Hurford R, Lee C A, Dumaop W, Rockenstein E & Masliah E, Type 1 diabetes exaggerates features of Alzheimer's disease in APP transgenic mice, Exp Neurol, 223 (2010) 422.
8. Trinder P, Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor, Annal Clin Biochem, 6 (1969) 24.
9. Nirogi R, Kandikere V, Mudigonda K, Bhyrapuneni G, Muddana N, Saralaya R & Benade V, A simple and rapid method to collect the cerebrospinal fluid of rats and its application for the assessment of drug penetration into the central nervous system, J Neurosci Meth, 178 (2009) 116.
10. Subramanian S & Divya Shree A N, Expression, purification and characterization of a synthetic gene encoding human amyloid ß (Aß1-42) in Escherichia coli, Indian J Biochem Biophys, 44 (2007) 71.
11. Brands A M, Biessels G J, de Haan E H F, Kappelle L J & Kessels R P C, The effects of type 1 diabetes on cognitive performance: a meta-analysis, Diabetes Care, 28 (2005) 726.
12. Kim B, Backus C, Oh S, Hayes J M & Feldman E L, Increased tau phosphorylation and cleavage in mouse models of type 1 and type 2 diabetes, Endocrinology, 150 (2009) 5294.
13. Moreira P I, Santos M S, Seica R & Oliveira C R, Brain mitochondrial dysfunction as a link between Alzheimer's disease and diabetes, J Neurol Sci, 257 (2007) 206.
14. Sharma S, Prasanthi R P J, Schommer E, Feist G & Ghribi O, Hypercholesterolemia-induced Aß accumulation in rabbit brain is associated with alteration in IGF-1 signaling, Neurobiol Dis, 32 (2008) 426.
15. Sims-Robinson C, Kim B, Rosko A & Feldman E L, How does diabetes accelerate Alzheimer disease pathology? Nat Rev Neurol, 6 (2010) 551.
16. Thorne R G, Pronk G J, Padmanabhan V & Frey W H II. Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration, Neuroscience, 127 (2004) 481.
17. Benedict C, Hallschmid M, Hatke A, Schultes B, Fehm H L, Born J & Kern W, Intranasal insulin improves memory in humans, Psychoneuroendocrinology, 29 (2004) 1326.
18. Yu Y P, Xu Q Q, Zhang Q, Zhang W P, Zhang L H & Wei E Q, Intranasal recombinant human erythropoietin protects rats against focal cerebral ischemia, Neurosci lett, 387 (2005) 5.
19. Wang D, Gao Y & Yun L, Study on brain targeting of raltitrexed following intranasal administration in rats, Cancer Chemother Phamacol, 57 (2005) 97.
20. Reger M A, Watson G S, Green P S, Wilkinson C W, Baker L D, Cholerton B, Fishel M A, Plymate S R, Breitner J C S, DeGroodt W, Mehta P & Craft S, Intranasal insulin improves cognition and modulates ß-amyloid in early AD, Neurology, 70 (2008) 440.